Coya Therapeutics Inc. (COYA)

AI Score

Unlock

6.17

-0.36 (-5.51%)

At close: Apr 25, 2025, 9:59 AM

Coya Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021
Cash & Equivalents	38.34M	31.06M	36.58M	35.99M	32.63M	10.89M	13.1M	16.32M	5.93M	8.65M	10.39M	-4.34M	4.34M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	8.68M	n/a
Long-Term Investments	n/a	n/a	n/a	149.25K	11.25K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	-1	n/a	n/a	n/a	n/a	n/a	1.12M	258.25K	n/a	-4.34M	87.18K
Receivables	730.58K	n/a	n/a	n/a	7.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	n/a	n/a	n/a	n/a	n/a	936.35K	1.29M	1.01M	1.25M	n/a	1.00	n/a	n/a
Total Current Assets	44.31M	35.51M	39.89M	37.33M	41.2M	11.82M	14.39M	17.33M	7.18M	8.71M	10.51M	4.34M	4.58M
Property-Plant & Equipment	38.59K	45.43K	52.27K	59.11K	65.95K	72.79K	79.63K	86.47K	93.31K	100.15K	112.61K	n/a	120.67K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	38.59K	45.43K	52.27K	208.36K	77.2K	72.79K	79.63K	86.47K	1.21M	358.4K	112.61K	-4.34M	207.85K
Total Assets	44.35M	35.55M	39.94M	37.54M	41.27M	11.9M	14.47M	17.42M	8.4M	9.06M	10.63M	n/a	4.79M
Account Payables	1.59M	336.72K	1.88M	1.59M	1.16M	633.95K	237.58K	541.75K	1.82M	1.31M	1.26M	n/a	857.57K
Deferred Revenue	848.29K	573.09K	939.03K	689.67K	923.11K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	723.85K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	3.82M	2.32M	3.83M	4.32M	5.05M	1.81M	1.22M	1.27M	3.82M	2.58M	1.59M	n/a	1.15M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.97M	11.85M	10.45M	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	945.45K	1.22M	856.65K	681.29K	574.68K	n/a	n/a	541.75K	12.97M	11.85M	10.45M	n/a	857.57K
Total Liabilities	4.77M	3.54M	4.68M	5M	5.63M	1.81M	1.22M	1.27M	16.79M	14.42M	12.03M	n/a	1.15M
Total Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	12.97M	11.85M	10.45M	n/a	n/a
Common Stock	1.67K	1.52K	1.52K	1.46K	1.44K	996.00	996.00	996.00	259.00	259.00	1.48K	n/a	259.00
Retained Earnings	-40.74M	-37.82M	-33.8M	-30.91M	-25.86M	-27.12M	-23.7M	-20.61M	-17.87M	-14.76M	-10.74M	n/a	-5.62M
Comprehensive Income	n/a	n/a	n/a	-149.25K	-11.25K	-0.00	-0.00	-0.00	n/a	n/a	0.00	-5.15M	n/a
Shareholders Equity	39.58M	32.01M	35.26M	32.54M	35.65M	10.09M	13.25M	16.15M	-8.39M	-5.36M	-1.41M	3.64M	3.64M
Total Investments	n/a	n/a	n/a	149.25K	11.25K	n/a	n/a	n/a	n/a	n/a	n/a	8.68M	n/a